CureMatch
×
  • Patients
  • Physicians
  • About Us
  • News
    • CureMatch News
    • Validation and Research
    • Events and Conferences
  • Contact
  • en
    • es
Pieter van Rooyen, PhD

Pieter van Rooyen, PhD

CEO & PRESIDENT AT EDICO GENOME

Pieter has more than 20 years of experience inventing, developing and successfully commercializing technologies in industries including semiconductors, wireless, healthcare, life sciences, image processing and retail automation, with a portfolio of over 130 granted patents in these areas.

logo

+1 (858) 859-2873

FAX: +1 (858) 430-5813

Quick Links

  • Patients
  • Physicians
  • About CureMatch
  • News and Latest Posts
    • CureMatch News
    • Validation and Case Studies
    • Events and Conferences
    • Videos
  • Contact Us
  • FAQ

Latest News and Results

  • J&J Innovation Podcast Features CureMatch’s Stephane Richard Sep 10

    Tune in to the J&J Innovation Podcast series featuring CureMatch’s Stephane Richard. J&J’s host, Caroline...

  • Kolmogorov Complexity Methodologies Helps Fight Cancer Aug 21

    CureMatch shares theories of 'Kolmogorov Complexity' to optimize descriptor selection at AIMed Summit. Just as...

  • CureMatch Recognized as Best Artificial Intelligence (AI) Company in Healthcare Jul 12

    Recognized as the “Best AI-based Solution for Healthcare” by AI Breakthrough, an independent organization that...

© 2019 CureMatch, Inc. CureMatch is a registered trademark.
FAQ | Terms of Use | Privacy Policy | HIPAA Notice

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data

We’d like to send you a CureMatch PreciGENE® Sample Analysis

 

Sample CureMatch Report Download

  • This field is for validation purposes and should be left unchanged.

 

We value and respect your privacy and will not publish, share, or sell your contact information.

View Privacy Policy